Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Hemispherx BioPharma Company Profile (NYSE:HEB)

Consensus Ratings for Hemispherx BioPharma (NYSE:HEB) (?)
Ratings Breakdown: 1 Strong Buy Rating(s)
Consensus Rating:Strong Buy (Score: 4.00)
Consensus Price Target: $1.45 (517.28% upside)

Analysts' Ratings History for Hemispherx BioPharma (NYSE:HEB)
Show:
DateFirmActionRatingPrice TargetActions
4/2/2015Midtown PartnersInitiated CoverageStrong-Buy$1.45View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/21/2014Chardan CapitalInitiated CoverageBuy$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/22/2013 forward)